Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A2 | O00482 | 2/20 | 0.83 |
| ▸ | NR5A1 | Q13285 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | FABP3 | P05413 | 1/20 | 0.66 |
| ▸ | SELP | P16109 | 1/20 | 0.61 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.56 |
| ▸ | PTAFR | P25105 | 1/20 | 0.56 |
| ▸ | HTR1D | P28221 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.55 |
| ▸ | PRKCA | P17252 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31276170 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL10498201 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL31084795 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL4182988 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL13735582 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL234615 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL23834444 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL3730490 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL233018 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL31695681 | 1.00 | NR5A2 (0.83) | NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3114 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144803-A1 | LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF | EDEN OPHTHALMIC PTE LTD. (SG) | 2026-05-28 | — | — | US | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743094-A1 | LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF | Eden Ophthalmic Pte Ltd. (SG) | 2026-05-20 | — | — | EP | claimed |
| US-20260125681-A1 | DOUBLE-STRANDED RNAi AGENTS FOR TARGETING AND REGULATING HBV GENE EXPRESSION, AND A USE THEREOF | HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD. (CN) | 2026-05-07 | — | — | US | claimed |
| EP-4736848-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CATIONIC LIPID AND USE THEREOF | Shanghai Regenelead Therapies Co., Ltd. (CN) | 2026-05-06 | — | — | EP | claimed |
| EP-4737436-A1 | CATIONIC LIPID CONTAINING TWO TERTIARY AMINE GROUPS, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd (CN) | 2026-05-06 | — | — | EP | claimed |
| WO-2026090423-A1 | UNIVERSAL LNP COMPOSITIONS | PRIME MEDICINE, INC (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2026090328-A1 | WNT7a MRNA LIPID NANOPARTICLES FOR THERAPEUTIC USES | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260109732-A1 | LIPID AMINES | MODERNATX INC (US) | 2026-04-23 | — | — | US | claimed |
| WO-2016191556-A1 | LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2016-12-01 | — | — | WO | claimed |
| WO-2016186429-A1 | COMPOSITION FOR CANCER TREATMENT COMPRISING INDOCYANINE GREEN-LIPOSOME COMPOSITE | 고려대학교산학협력단 | 2016-11-24 | — | — | WO | claimed |
| EP-3072516-A1 | ANTIDEPRESSANT COMBINATION DRUG | Nishizaki Bioinformation Research Institute (JP) | 2016-09-28 | — | — | EP | claimed |
| US-20160235773-A1 | ANTIDEPRESSANT COMBINATION DRUG | NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE (JP) | 2016-08-18 | — | — | US | claimed |
| US-20140050780-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2014-02-20 | — | — | US | claimed |
| WO-2014021678-A1 | MICROBUBBLE-NANOLIPOSOME COMPLEX FOR CANCER DIAGNOSIS AND TREATMENT | (주)아이엠지티 (KR) | 2014-02-06 | — | — | WO | claimed |
| EP-2659892-A1 | CONCOMITANT DRUG FOR IMPROVING COGNITIVE FUNCTION | Nishizaki Bioinformation Research Institute (JP) | 2013-11-06 | — | — | EP | claimed |
| US-20130274228-A1 | CONCOMITANT DRUG FOR IMPROVING COGNITIVE FUNCTION | NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE (JP) | 2013-10-17 | — | — | US | claimed |
| EP-2444464-A1 | Novel neutral (bio)material | Centre National de la Recherche Scientifique (CNRS) (FR) | 2012-04-25 | — | — | EP | claimed |
| US-20020102297-A1 | Macromolecule-lipid complexes and methods for making and using | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-08-01 | — | — | US | claimed |